Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
Carlsmed (Nasdaq: CARL) said CEO and Chairman Mike Cordonnier will present at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Carlsmed (Nasdaq: CARL) said CEO and Chairman Mike Cordonnier will present at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans. A live webcast is available to registered participants and a replay will be posted afterward.
Details
News Market Reaction – CARL
On Feb 24, the first trading day after this news, CARL closed 0.08% above the previous close.
Data tracked by StockTitan Argus for the Feb 24 session.
Key Figures
- Conference date
- March 2, 2026
- Canaccord Genuity Musculoskeletal Conference presentation
- Presentation time
- 11:30 AM CST
- Scheduled slot at 2026 Canaccord Genuity Musculoskeletal Conference
Historical Context
-
First personalized corra cervical plating procedure ahead of commercial launch.
-
Announcement of upcoming Q4 and full-year 2025 results call date.
-
First aprevo lumbar bi-lateral posterior fusion procedure at major hospital.
-
Strong preliminary Q4 and 2025 revenue growth versus prior year levels.
-
Peer-reviewed 2-year data showing reduced revision rates with aprevo implants.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
musculoskeletal medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.
A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz
About Carlsmed, Inc.
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com
Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.